News from us and our partners

Tags

Topics

0 results

News
10 June, 2026
Sensorion Achieves Key Regulatory Milestones for SENS-601 for GJB2-related Hearing Loss and Selects Program as Lead Gene Therapy Candidate
News
9 June, 2026
Moon Surgical expands Maestro® platform into a multi-model physical AI platform with software Version 2.7
News
4 June, 2026
Muna Therapeutics Announces Nature Medicine Publication Validating Microglial State Transitions as Key Drivers of Alzheimer’s
News
3 June, 2026
Ingenix raises €13M led by Sofinnova to scale Modality Fusion AI
News
1 June, 2026
Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis
News
29 May, 2026
CorWave Achieves Major Regulatory Milestone with ISO 13485 Certification Across its Entire Operations
Feature
27 May, 2026
2025 Impact Report: focusing on the future of industrial biotech
News
26 May, 2026
NodThera Announces the Publication and Presentation of Cardiometabolic Clinical Data Supporting the Potential of Ruvonoflast to Treat Inflammation at the Source
News
26 May, 2026
Artios Announces First Patient Dosed in Randomized Phase 2 POLKA Study Evaluating DNA Polymerase Theta Inhibitor ART6043 in gBRCA-mutated HER2-Negative Breast Cancer
News
26 May, 2026
P2 Science raises $23M to expand green chemistry platform
News
20 May, 2026
HAYA Therapeutics doses first cohort in Phase 1 trial
News
18 May, 2026
Tulyp Medical appoints Steve Motes as CEO
News
18 May, 2026
Baxfendy approved in the US for hypertension
News
18 May, 2026
Galvanize Therapeutics Receives FDA Clearance for Aliya EX Generator, Expanding its Aliya Pulsed Electric Field Portfolio for Surgical Ablation of Soft Tissue
News
18 May, 2026
Sensorion appoints Fred Chereau as CEO
News
13 May, 2026
Sitryx First-in-Class Oral PKM2 Modulator SYX-5219 Phase 1a Trial Data to be Presented at SID 2026

Sensorion Achieves Key Regulatory Milestones for SENS-601 for GJB2-related Hearing Loss and Selects Program as Lead Gene Therapy Candidate

Moon Surgical expands Maestro® platform into a multi-model physical AI platform with software Version 2.7

Muna Therapeutics Announces Nature Medicine Publication Validating Microglial State Transitions as Key Drivers of Alzheimer’s

Ingenix raises €13M led by Sofinnova to scale Modality Fusion AI

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis

CorWave Achieves Major Regulatory Milestone with ISO 13485 Certification Across its Entire Operations

2025 Impact Report: focusing on the future of industrial biotech

NodThera Announces the Publication and Presentation of Cardiometabolic Clinical Data Supporting the Potential of Ruvonoflast to Treat Inflammation at the Source

Artios Announces First Patient Dosed in Randomized Phase 2 POLKA Study Evaluating DNA Polymerase Theta Inhibitor ART6043 in gBRCA-mutated HER2-Negative Breast Cancer

P2 Science raises $23M to expand green chemistry platform

HAYA Therapeutics doses first cohort in Phase 1 trial

Tulyp Medical appoints Steve Motes as CEO

Baxfendy approved in the US for hypertension

Galvanize Therapeutics Receives FDA Clearance for Aliya EX Generator, Expanding its Aliya Pulsed Electric Field Portfolio for Surgical Ablation of Soft Tissue

Sensorion appoints Fred Chereau as CEO

Sitryx First-in-Class Oral PKM2 Modulator SYX-5219 Phase 1a Trial Data to be Presented at SID 2026